Matthew A. Cooper

Active 1980–2025

Also published as
Matthew A Cooper
143
Papers
30,696
Citations
86
h-index
140
i10-index

Citations

Citations per year for Matthew A. Cooper1980: 4 citations1981: 10 citations1982: 5 citations1983: 4 citations1984: 4 citations1985: 6 citations1986: 3 citations1987: 2 citations1988: 4 citations1989: 2 citations1991: 1 citations1993: 1 citations1996: 6 citations1998: 1 citations1999: 3 citations2000: 5 citations2001: 29 citations2002: 56 citations2003: 44 citations2004: 60 citations2005: 70 citations2006: 65 citations2007: 61 citations2008: 61 citations2009: 55 citations2010: 66 citations2011: 67 citations2012: 79 citations2013: 92 citations2014: 128 citations2015: 150 citations2016: 241 citations2017: 454 citations2018: 540 citations2019: 1,436 citations2020: 1,916 citations2021: 1,957 citations2022: 1,813 citations2023: 1,342 citations2024: 1,710 citations2025: 952 citations2026: 25 citations1990: no citations, so this year is not shown1992: no citations, so this year is not shown1994–1995: no citations, so these years are not shown1997: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 3,412 citing papers, 20.1% of this breakdownChina: 3,267 citing papers, 19.2% of this breakdownUnited Kingdom: 955 citing papers, 5.6% of this breakdownGermany: 943 citing papers, 5.6% of this breakdownAustralia: 825 citing papers, 4.9% of this breakdownItaly: 544 citing papers, 3.2% of this breakdownIndia: 495 citing papers, 2.9% of this breakdownCanada: 484 citing papers, 2.8% of this breakdownFrance: 447 citing papers, 2.6% of this breakdownSpain: 368 citing papers, 2.2% of this breakdownJapan: 356 citing papers, 2.1% of this breakdownNetherlands: 310 citing papers, 1.8% of this breakdown
0%20.1%Other 27%

Fields

  • Biochemistry, Genetics and Molecular Biology42.3%
  • Medicine31.8%
  • Immunology and Microbiology10.1%
  • Neuroscience3.7%
  • Engineering2.1%
  • Agricultural and Biological Sciences1.9%
  • Other8.1%

Topics

  • Inflammasome and immune disorders8.3%
  • Gut microbiota and health2.6%
  • Antibiotic Resistance in Bacteria1.7%
  • Neuroinflammation and Neurodegeneration Mechanisms1.7%
  • Antimicrobial Peptides and Activities1.6%
  • Acute Myeloid Leukemia Research1.3%
  • Other82.8%

Coauthors

All papers

Open in search
  1. A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases

    Authors: , , , , , , , , , , , , , , , , , , , , , - Nature Medicine 2015 cited by 2,784

  2. Clonal hematopoiesis associated with TET2 deficiency accelerates atherosclerosis development in mice

    Authors: , , , , , , , , , , , , , , , , , , - Science 2017 cited by 1,531

  3. Emerging pathogenic links between microbiota and the gut–lung axis

    Authors: , , , , , , - Nature Reviews Microbiology 2016 cited by 1,572

  4. NLRP3 inflammasome blockade reduces liver inflammation and fibrosis in experimental NASH in mice

    Authors: , , , , , , , , , , , , , , - Journal of Hepatology 2017 cited by 1,070

  5. Inflammasome inhibition prevents α-synuclein pathology and dopaminergic neurodegeneration in mice

    Authors: , , , , , , , , , , , , , - Science Translational Medicine 2018 cited by 890

  6. Tet2-Mediated Clonal Hematopoiesis Accelerates Heart Failure Through a Mechanism Involving the IL-1β/NLRP3 Inflammasome

    Authors: , , , , , , , , , , , - Journal of the American College of Cardiology 2018 cited by 677

  7. Inhibiting the NLRP3 inflammasome with MCC950 promotes non-phlogistic clearance of amyloid-β and cognitive function in APP/PS1 mice

    Authors: , , , , , , , , , - Brain Behavior and Immunity 2016 cited by 568

  8. Human Monocytes Engage an Alternative Inflammasome Pathway

    Authors: , , , , , , , , , - Immunity 2016 cited by 760

  9. K + Efflux-Independent NLRP3 Inflammasome Activation by Small Molecules Targeting Mitochondria

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - Immunity 2016 cited by 523

  10. Metal complexes as a promising source for new antibiotics

    Authors: , , , , , , , , , , , , , , , , , , , , , , - Chemical Science 2020 cited by 513

  11. T helper 1 immunity requires complement-driven NLRP3 inflammasome activity in CD4 + T cells

    Authors: , , , , , , , , , , , , , , , , , , , , , - Science 2016 cited by 511

  12. NLRP3 inflammasome activation downstream of cytoplasmic LPS recognition by both caspase‐4 and caspase‐5

    Authors: , , , , , , , , , , , , , , - European Journal of Immunology 2015 cited by 356

  13. Pharmacological inhibition of the NLRP3 inflammasome reduces blood pressure, renal damage, and dysfunction in salt-sensitive hypertension

    Authors: , , , , , , , , , , , , , , , , , - Cardiovascular Research 2018 cited by 269

  14. Role for NLRP3 Inflammasome–mediated, IL-1β–Dependent Responses in Severe, Steroid-Resistant Asthma

    Authors: , , , , , , , , , , , , , , , , , , , - American Journal of Respiratory and Critical Care Medicine 2017 cited by 435

  15. Genomic characterization of the uncultured Bacteroidales family S24-7 inhabiting the guts of homeothermic animals

    Authors: , , , , , , , , , , , , - Microbiome 2016 cited by 694

  16. The NLRP3 inflammasome functions as a driver of the myelodysplastic syndrome phenotype

    Authors: , , , , , , , , , , , , , , , , , , , - Blood 2016 cited by 346

  17. Myeloid-derived miR-223 regulates intestinal inflammation via repression of the NLRP3 inflammasome

    Authors: , , , , , , , , , , , , , , , , , , - The Journal of Experimental Medicine 2017 cited by 359

  18. Pharmacological Inhibition of the Nod-Like Receptor Family Pyrin Domain Containing 3 Inflammasome with MCC950

    Authors: , , - Pharmacological Reviews 2021 cited by 164

  19. The microglial NLRP3 inflammasome is activated by amyotrophic lateral sclerosis proteins

    Authors: , , , , , , , , , , , - Glia 2019 cited by 234

  20. TET2-Loss-of-Function-Driven Clonal Hematopoiesis Exacerbates Experimental Insulin Resistance in Aging and Obesity

    Authors: , , , , , , , , , , , , - Cell Reports 2020 cited by 203

  21. An amphipathic peptide with antibiotic activity against multidrug-resistant Gram-negative bacteria

    Authors: , , , , , , , , , , , , , , , , - Nature Communications 2020 cited by 197

  22. Interleukin-1β suppression dampens inflammatory leucocyte production and uptake in atherosclerosis

    Authors: , , , , , , , , , , , , , , , , , , , , , - Cardiovascular Research 2021 cited by 104

  23. The selective NLRP3-inflammasome inhibitor MCC950 reduces infarct size and preserves cardiac function in a pig model of myocardial infarction

    Authors: , , , , , , , , , , - European Heart Journal 2016 cited by 322

  24. Targeting the NLRP3 Inflammasome With Inhibitor MCC950 Prevents Aortic Aneurysms and Dissections in Mice

    Authors: , , , , , , , , , , , - Journal of the American Heart Association 2020 cited by 117